Patents by Inventor Matthew NUNEZ

Matthew NUNEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prediction of therapeutic response in inflammatory conditions
    Patent number: 11208694
    Abstract: Response to treatment of an inflammatory condition can be predicted based on characteristics of one or more markers from a subject. The markers can include expressions of nucleotide sequences identified herein and of combinations thereof. A response value can be calculated based on characteristics (e.g., expression levels) of one or more of the markers, as well as other characteristics of the subject, such as baseline clinical data. The treatment can be administered when the response value is beyond a threshold.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 28, 2021
    Assignee: LIQUID BIOSCIENCE, INC.
    Inventors: Patrick Lilley, Matthew Nunez
  • PREDICTION OF THERAPEUTIC RESPONSE IN INFLAMMATORY CONDITIONS
    Publication number: 20180142301
    Abstract: Response to treatment of an inflammatory condition can be predicted based on characteristics of one or more markers from a subject. The markers can include expressions of nucleotide sequences identified herein and of combinations thereof. A response value can be calculated based on characteristics (e.g., expression levels) of one or more of the markers, as well as other characteristics of the subject, such as baseline clinical data. The treatment can be administered when the response value is beyond a threshold.
    Type: Application
    Filed: December 18, 2017
    Publication date: May 24, 2018
    Inventors: Patrick LILLEY, Matthew NUNEZ
  • Prediction of therapeutic response in inflammatory conditions
    Patent number: 9845505
    Abstract: Response to treatment of an inflammatory condition can be predicted based on characteristics of one or more markers from a subject. The markers can include expressions of nucleotide sequences identified herein and of combinations thereof. A response value can be calculated based on characteristics (e.g., expression levels) of one or more of the markers, as well as other characteristics of the subject, such as baseline clinical data. The treatment can be administered when the response value is beyond a threshold.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: December 19, 2017
    Assignee: BLUEPRINT BIO, INC.
    Inventors: Patrick Lilley, Matthew Nunez
  • PREDICTION OF THERAPEUTIC RESPONSE IN INFLAMMATORY CONDITIONS
    Publication number: 20170218448
    Abstract: Response to treatment of an inflammatory condition can be predicted based on characteristics of one or more markers from a subject. The markers can include expressions of nucleotide sequences identified herein and of combinations thereof. A response value can be calculated based on characteristics (e.g., expression levels) of one or more of the markers, as well as other characteristics of the subject, such as baseline clinical data. The treatment can be administered when the response value is beyond a threshold.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 3, 2017
    Applicant: BluePrint Bio, Inc.
    Inventors: Patrick LILLEY, Matthew NUNEZ